Join to View Full Profile
259 E Erie StSte 1600Chicago, IL 60611
Phone+1 312-695-5620
Fax+1 312-695-2729
Dr. Dulai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2017
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2010 - 2014
Dayanand Medical College Class of 2009
Certifications & Licensure
NH State Medical License 2013 - Present
IL State Medical License 2021 - 2026
CA State Medical License 2014 - 2023
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Sherman Emerging Leader Prize 2022
Clinical Trials
- Hyperbaric Oxygen for Ulcerative Colitis Start of enrollment: 2013 Aug 01
- Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares Start of enrollment: 2017 Sep 07
Publications & Presentations
PubMed
- Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward.John Grady, Kevin M Johnson, Richard Kellermayer, Harland S Winter, James H Tabibian
Expert Review of Gastroenterology & Hepatology. 2026-02-20 - Impact of Comorbid Psoriasis on the Efficacy of Ustekinumab and Mirikizumab in Inflammatory Bowel Disease: A Post-hoc Analysis of UNITI, SEAVUE, and LUCENT.Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
Digestive Diseases and Sciences. 2026-02-19 - Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis With Severe Endoscopic Disease.Emily C L Wong, Vipul Jairath, Parambir S Dulai, John K Marshall, Christopher Ma
The American Journal of Gastroenterology. 2026-02-02
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel DiseasesWaseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
- Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis ConceptsParambir S Dulai, William J Sandborn, Brigid S Boland, Derek R Patel, Inflammatory Bowel Diseases
Press Mentions
How a Common Metabolite Worsens Inflammatory Bowel DiseaseJune 30th, 2025- New ‘Molecular GPS’ Will Fast-Track Drug DiscoveryJune 16th, 2025
- Learn Best Practices for IBD Shared Decision-Making and Treatment SelectionFebruary 11th, 2025
Grant Support
- Selenium Supplementation for Moderate-Severe Ulcerative Colitis FlaresNORTHWESTERN UNIVERSITY AT CHICAGO2025–2028
- Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled TrialNORTHWESTERN UNIVERSITY AT CHICAGO2023–2028
- Identifying Neutrophil Specific Mechanisms for Resistance to Biologics in Ulcerative ColitisNORTHWESTERN UNIVERSITY AT CHICAGO2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
